NMP22 is a nuclear protein selectively expressed by cancers of the bladder and upper urinary tract, whereas BTA is produced by the digestion of extracellular matrix in the basement membranes of bladder and upper urinary tract cancers.4 The gene discussed is NUMA1; the disease is urinary bladder cancer.